Kite Pharma Appoints Leading Cancer Immunotherapy Experts to its Scientific ... PR Newswire (press release) He was the first to successfully treat human lymphoma with a monoclonal antibody, and made important contributions to the development of rituximab (Rituxan®) for the treatment of lymphoma. Dr. Levy has received international acclaim for his work ... |
